SPIE SPIE SA

Press release - SPIE announces the acquisition of Spefinox in France

Press release - SPIE announces the acquisition of Spefinox in France

Cergy, 9 October 2024 - SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the acquisition of 88% of Spefinox, an expert player in industrial processes for the agri-food, cosmetics and pharmaceuticals sectors.

Founded in 1999 and based in Quiévrechain (Nord), Spefinox designs and manufactures specialised equipment for industrial processes. Thanks to this acquisition, SPIE strengthens its expertise in industrial processes in the agri-food, cosmetics and pharmaceuticals sectors within its French subsidiary SPIE Industrie. With approximately 25 qualified employees, Spefinox generated revenue of €6.6 million in 2023.

Frédéric Toussaint, Managing Director of SPIE Industrie, said: "We are delighted to welcome new teams into SPIE Industrie in the Nord in France. Leveraging the advanced expertise of its employees in industrial processes, Spefinox benefits from a well-established know-how and a strong and recurring customer base."

About SPIE

SPIE is the independent European leader in multi-technical services in the areas of energy and communications. Our 50,000 employees are committed to achieving the energy transition and digital transformation alongside our customers.

SPIE achieved in 2023 consolidated revenues of €8.7 billion and consolidated EBITA of €584 million.



Attachment



EN
09/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SPIE SA

Carole Braudeau
  • Carole Braudeau

Credit Morning 03/06/2026

Banijay Group achieves its 2025 targets except for growth in TV content business|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 06/03/2026

Banijay Group atteint ses objectifs 2025 hormis pour la croissance de l’activité de contenus TV|

Christophe Chaput
  • Christophe Chaput

ResearchPool Subscriptions

Get the most out of your insights

Get in touch